Novel solubleCD83 polypeptides, formulations and methods of use

Details for Australian Patent Application No. 2009249540 (hide)

Owner Argos Therapeutics, Inc.

Inventors Brand, Stephen; Moo-Young, Murray; Chou, Chih-Hsiung

Agent Griffith Hack

Pub. Number AU-A-2009249540

PCT Pub. Number WO2009/142759

Priority 61/128,709 23.05.08 US

Filing date 22 May 2009

Wipo publication date 26 November 2009

International Classifications

A61K 48/00 (2006.01) Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases

A61K 38/17 (2006.01) Medicinal preparations containing peptides - from animals

Event Publications

2 December 2010 PCT application entered the National Phase

  PCT publication WO2009/142759 Priority application(s): WO2009/142759

20 January 2011 Corrigenda

  PCT applications that have entered the National Phase - Name Index Under the name Argos Therapeutics, Inc., Application No. 2009249540, under INID (54) correct the title to read Novel soluble CD83 polypeptides, formulations and methods of use

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2009249541-Antimicrobial compositions and methods of use

2009249523-Supplier funds reception electronically